A study investigating how an individual’s genome impacts their response to the Ebola virus has kicked off in Monrovia. It enrolled its first 15 volunteers on 4 September.
Prevail 6 is sponsored by the United States National Institutes of Allergy and Infectious Diseases and the Liberian ministry of health. It is led by Liberian and US researchers.
The study will gather 8,500 samples, of which 2,000 will be from Ebola survivors. Another 3,000 samples will be taken from people who were in close contact with infected people during the country’s recent outbreak but who were not themselves infected.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.